Compare Metaphore Pharmaceuticals vs Slate Pharmaceuticals
Customers evaluate the quality of Metaphore Pharmaceuticals's products using the following success metrics.
Overview
Metaphore Pharmaceuticals is 26 yrs old and is based in United States.
Metaphore leads the emerging pharmaceutical frontier with its introduction of SOD mimetics, aka superoxide dismutase mimetic (SODm), which mimic, supplement, and enhance the human body's enzyme activity. Methaphore's products can be administered orally or topically as well as made into an aerosol. The company was founded in 1998 by Garland Marshall. Drug maker ActivBiotics plans to acquire the company
Slate Pharmaceuticals is based in United States
Slate currently markets Testopel in the United States. Testopel is an FDA-approved subcutaneous implantable testosterone pellet. Testopel is used for the treatment of testosterone deficiency in aging men as well as androgen deficiency caused by other conditions.
Demo Video
Leadership
Alan W Dunton (Chief Executive Officer, President)
Robert S Whitehead (Chief Executive Officer)
Funding
Investors
ActivBiotics, Prolog Ventures
Product
Benefits
Products
Customers
Known Partners
Why They Buy
Information not available because Metaphore Pharmaceuticals has not claimed their profile.
Work for Metaphore Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Metaphore Pharmaceuticals?
Claim your profile now.
Information not available because Slate Pharmaceuticals has not claimed their profile.
Work for Slate Pharmaceuticals? Claim your profile by submitting an Analyst Briefing. By submitting you can
Work for Slate Pharmaceuticals?
Claim your profile now.